Future for VHL kidney cancer is bright
Von Hippel-Lindau (VHL) disease–associated renal cell carcinoma (RCC) has always [...]
γ-Glutamyltransferase as a biomarker in patients on nivolumab for metastatic kidney cacner
A protein called γ-glutamyltransferase can predict survival in patients with [...]
Cabozantinib plus atezolizumab combination for advanced kidney cancer
In this study, two doses of cabozantinib were tested in [...]
Everolimus and bevacizumab for advanced papillary kidney cancer
In this phase 2 clinical trial, a combination of everolimus [...]
New survival data for pembrolizumab plus axitinib in advanced kidney cancer
A paper published in The Lancet Oncology this month provides [...]
Avelumab plus axitinib combintion approved for untreated advanced kidney cancer in Scotland
The Sottish Medicine Consortium (SMC) have issued a final decision to recommend [...]
Quality versus quantity of life with cabozantinib and sunitinib in advanced kidney cancer
Cabozantinib and sunitinib are both drugs that block the development [...]
Safety and efficacy of TiNivo in patients with metastatic kidney cancer
Tivozanib is a drug that blocks the blood supply to [...]
Association between TKI-induce high blood pressure and outcomes in patients with kidney cancer
In this retrospective study published in Cancer Reports the association [...]
Safety and efficacy of apatinib for metastatic kidney cancer
A recent study coming out of China has identified a [...]
